Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery
Public ClinicalTrials.gov record NCT03015961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: The primary objective of this study is to compare postsurgical pain control following local infiltration analgesia (LIA) with EXPAREL admixed with bupivacaine HCl versus LIA with bupivacaine HCl in adult subjects undergoing open lumbar posterior spinal fusion surgery. Secondary Objectives: The secondary objectives of this study are to compare additional efficacy, safety, and health economic outcomes following LIA with EXPAREL admixed with bupivacaine HCl versus LIA with bupivacaine HCl in adult subjects undergoing open lumbar posterior spinal fusion surgery.
Study identification
- NCT ID
- NCT03015961
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 38 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2017 (Actual)
- Primary completion
- Oct 30, 2017 (Actual)
- Completion
- Oct 30, 2017 (Actual)
- Last update posted
- Oct 13, 2021
2017
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| OrthoArizona | Gilbert | Arizona | 85295 | — |
| St. Joseph's Hospital | Phoenix | Arizona | 85013 | — |
| UC Davis | Sacramento | California | 95817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beaumont Health | Troy | Michigan | 48085 | — |
| Washington Univ | St Louis | Missouri | 63110 | — |
| Icahn School of Medicine | New York | New York | 10029 | — |
| OrthoCarolina | Charlotte | North Carolina | 28207 | — |
| Ohio State Univ | Columbus | Ohio | 43210 | — |
| Thomas Jefferson University of Neurosurgery | Philadelphia | Pennsylvania | 19107 | — |
| Central Texas Spine Institute | Austin | Texas | 78731 | — |
| Baylor Scott & White | Temple | Texas | 76508 | — |
| Univ of Virginia | Charlottesville | Virginia | 22903 | — |
| Colonial Orthopaedics | Colonial Heights | Virginia | 23834 | — |
| West Virginia University Hospitals | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03015961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03015961 live on ClinicalTrials.gov.